scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMSB020574 |
P698 | PubMed publication ID | 12324562 |
P50 | author | Peter Q Eichacker | Q64827097 |
P2093 | author name string | Anthony F Suffredini | |
Robert S Munford | |||
H Shaw Warren | |||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
drotrecogin alfa | Q412888 | ||
P1104 | number of pages | 4 | |
P304 | page(s) | 1027-1030 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Risks and benefits of activated protein C treatment for severe sepsis | |
P478 | volume | 347 |